General Archive
-
News releasesLifeArc Ventures – strong performance in 2022 & sustained investment in innovation
LifeArc Ventures, which is committed to investing in innovative early-stage life science companies, provides an update on its portfolio.
-
News releasesLifeArc portfolio company RQ Bio’s antibody enters clinical trials
The first of RQ Bio’s discovered monoclonal antibodies to prevent COVID-19 in vulnerable patients has entered clinical trials.
-
News releasesLifeArc Ventures invests in Surgery Hero, world’s first digital coaching clinic for patients
Seed funding will be used to scale the solution through the application of machine learning
-
LifeArc supports MRC spin-out to Series A funding
Our technology transfer team has helped the Medical Research Council (MRC), a founder in PepGen, to advance a novel technology…
-
Jump starting research: SpringWorks Therapeutics – unlocking science
LifeArc’s joint venture with Pfizer, Bain Capital and OrbiMed With a purpose of working in partnership with patient foundations and…